Asthma/COPD Flashcards

1
Q

Two main pharmacologic classes

A
Anti-inflammatory agents
•Glucocorticoids (inhaled, oral)
–Bronchodilators
•Beta2-adrenergic agonists (long
and short-acting)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Inhalation drug therapy advantages

A

Advantages
– Therapeutic effects are minimized
– Relief of acute attacks is rapid
– Systemic effects are minimized

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Types of inhaled medications

A

– Metered-dose inhalers (MDI)
– Respimats
– Dry-powder inhalers (DPIs).
– Nebulizers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

inhallations should be seperated by

A

one minute

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is recomended to use withan inhaler

A

spacer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is considered to deliver more drug to the lungs and does not require a spacer. This is activated by the air of the lungs

A

Dry powder inhaler

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what type of inhaler uses a spacer

A

MDI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What question should you ask during a follow up

A

how is the pt using the inhaller. If they are not using it corrctly they won’t get the right amount of medicine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Anti-inflamatory are the ___ of asthma therpay and are taken ___ for long term conrol

A

foundation

daily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Principal anti-inflamatory drugs are ____

A

inhalled glucocorticoids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

examples of inhalled glucocorticoids

A

– Beclomethasone dipropionate [QVAR]
– Budesonide [Pulmicort]
– Fluticasone [Flovent]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Glucocorticoids - MOA

A

– Suppress inflammation
– Most effective anti-asthma drug
– Decrease synthesis and release of inflammatory mediators
– Reduce infiltration and activity of inflammatory cells
– Decrease edema of the airway mucosa caused by beta2
agonists
– Reduce bronchial hyperactivity and decrease airway
mucus production
– May increase the # of bronchial beta2 receptors and their
responsiveness to beta2 agonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

most effective anti-asthma drug

A

glucocorticoids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

glucocorticoids may increase the number of

A

bronchial beta 2 receptors asnd theary responsiveness to bet2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Important pt education for glucocorticoids

A

preventative medication. Must be taken daily. not used as abortive medication. benificial effects develop slowly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Inhaled - first-line therapy for management of inflammatory component of asthma

A

glucocorticoids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

inhaled glucocortioid is safeter than

A

systemic version

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

SE of glucocortioid

A

• Oropharyngeal candidiasis, dysphonia = most common

adrenal suppression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Oral glucocorticoid use

A

– Management of acute exacerbations
– Short burst, use shortest duration possible
– Use when symptoms cannot be controlled with safer
medications.

20
Q

Oral glucocorticoid ADR

A

Adverse effects: adrenal suppression, osteoporosis,
hyperglycemia, peptic ulcer disease.
• Growth suppression in the young patient.

21
Q

Oral glucocortoid recomendatiosn to avoid Adverse effects

A

eat calcium. Weight bearing exercise. Vit d

22
Q

High dose inhalled glucocortoid ADR

A

catarax and glacoma

23
Q

should use oral glucocortoic less than

A

10 days. Really the shortest duration possible

24
Q

• Prolonged glucocorticoid use can decrease

A

the ability
of the adrenal cortex to produce glucocorticoids of its
own

25
Q

High levels of glucocorticoids are required to s

A

o survive

severe stress

26
Q

Adrenal suppression prevents p

A

production of

endogenous glucocorticoids

27
Q

Patients must be given increased doses of

A

oral or IV

glucocorticoids at times of stress

28
Q

failure to increase dose of glucocorticoids during times of stress

A

can prove fatal

29
Q

addrenal supression is life threatnein gat times of

A

s of severe physiologic stress

e.g., surgery, trauma, or systemic infection

30
Q

Discontinuation of systemic glucocorticoid

A

– Most be done slowly
– Recovery of adrenocortical function takes
several months
– Dosages of exogenous sources must be
gradually reduced
– During this patient must be given oral or IV
glucocorticoids at times of severe stress

31
Q

In children there is A dose-dependent reduction in bone

formation with use of

A

inhaled corticosteroids

32
Q

• Vitamin D and calcium sufficiency should

be ensured with

A

adequate dietary intake of

vitamin D and calcium

33
Q

Oral Glucocorticoids examples

A

Prednisone, methylprednisolone,

prednisolone

34
Q

Oral Glucocorticoids adult dose

A

40 to 60mg/day for 3 to 10 days

35
Q

Oral Glucocorticoids pediatric dose

A

1 to 2 mg/kg/day for 3 to 10

days

36
Q

Oral Glucocorticoids SE

A

increased appetite. Increased energy.

37
Q

Oral Glucocorticoids recomendations

A

take with food. taper dose 60, 40, 20 ect.

38
Q

Leukotriene Modifiers action

A

suppress effects of leukotrienes

39
Q

leukotriens

A

Promote smooth muscle
constriction, blood vessel permeability, and
inflammatory responses through direct action
and recruitment of eosinophils and other
inflammatory cells

40
Q

In patients with asthma, leukotriene

modifiers can reduce

A

bronchoconstriction
and inflammatory responses such as
edema and mucus secretion

41
Q

Leukotriene modifieres are considered

A

second line agents.

42
Q

Leukotriene modifiers Adverse Neuopsychiatric effects

A

including

depression, suicidal thinking, and suicidal behavior

43
Q

• Zileuton [Zyflo] action and monitoring

A

– blocks leukotriene synthesis

– Monitor ALT (one a month for 3 months, then every 2
to 3 months x 1 year, then periodically).

44
Q

Montelukast [Singulair} MOA

A

Leukotriene Receptor Blocker

45
Q

Montelukast three indications

A

– 1. Prophylaxis and maintenance therapy
– 2. Prevention of EIB >15 y.o.
– 3. Relief of allergic rhinitis

46
Q

Montelukast Side Effects

A

Neuropsychiatric effects

47
Q

No serious drug interactions with

A

Montelukast